Respiratory Syncytial Virus Infection
Pediatric RSV Prevention: Advances in Disease State, Immunization, and Interprofessional Care
This activity is supported by an educational grant from Sanofi US.
Updates in Preventing Pediatric RSV: Rapid Response From IDWeek
This activity is supported by an educational grant from Sanofi US.
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
The investigational antiviral ziresovir showed promise for the treatment of respiratory syncytial virus infection in infants during a phase 3 trial in China, researchers reported in The New England Journal of Medicine.
Patients with IBD at increased risk for respiratory syncytial virus infection
VANCOUVER, British Columbia — Adult patients with inflammatory bowel disease are at increased risk for respiratory syncytial virus infection and hospitalization, especially those with comorbidities, according to data presented here.
RSV hospitalizations linked to ‘considerable’ health care burden in Europe
One in 56 infants born healthy in Europe between July 2017 and April 2020 was hospitalized due to respiratory syncytial virus, or RSV, according to study results published in The Lancet Respiratory Medicine.
Q&A: ‘Atypical’ increase of RSV cases in children may be due to waning immunity
CDC data have shown a spike in respiratory syncytial virus cases among children, with incidence occurring earlier in the season than what is typically seen and anecdotal accounts of pediatric hospitals reporting they are at capacity.